help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolff, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolff, G. T.
Am. J. Respir. Crit. Care Med., Volume 158, Number 1, July 1998, 341-342

A REANALYSIS OF THE OZONE/ ASTHMA RELATIONSHIP

To the Editor:

Thurston and colleagues (1) conclude that there are monotonic relationships between ozone (O3) and (1) reduced lung function, (2) increased number of asthma symptoms, and (3) increased use of asthma medication in asthmatic children at concentrations well below the 1-h standard of 120 ppb. The primary basis for these conclusions is the data plotted in Figure 1 of their paper. Since it appeared to me that the linear lines derived from their regression analyses were heavily influenced by a small number of data points at the highest concentrations, I decided to test the robustness of the regressions by removing some of the higher values.

I reconstructed their data set by interpolating the data contained in Figure 1 of their paper. To see how close the reconstructed data was to their data, I tried to reproduce their regression lines and correlation coefficients. Although, I could not reproduce them exactly, I believe they are close enough for the purposes of this exercise. The relationships I found were: peak flow difference -0.071 O3 + 27.7 (r = -0.44); medication use = 0.0017 O3 + 0.23 (r = 0.58); symptoms = 0.0029 O3 + 0.33 (r = 0.68). These compare with the relationships that they report: peak flow difference -0.073 O3 + 27.5 (r = -0.43); medication use = 0.0018 O3 + 0.22 (r = 0.62); symptoms = 0.0029 O3 + 0.31 (r = 0.71).

When I removed the days with the two highest O3 concentrations (160 and 147 ppb), the relationship between peak flow difference and O3 was not significant as the r decreased to -0.11 and the slope of the regression line decreased to -0.02 with a standard error of ± 0.05. For the other two health endpoints, it was necessary to delete the four highest O3 days before the relationships became nonsignificant. Incidentally, removal of the four highest days removes only the days which experienced O3 greater than or equal to the present 1-h standard of 120 ppb. For the medication/O3 relationship, r decreased to 0.09 and the slope to 0.0003, with a standard error of ± 0.0011. For the symptoms/O3 relationship, the r decreased to 0.07 and the slope to 0.0002, with a standard error of ± 0.001.

Thus, when the days on which O3 was equal to or greater than the current 1-h standard are eliminated from the analysis, the remaining data do not support the conclusion of monotonic relationships. This is an extremely important issue because EPA extrapolates reported dose-response functions to the entire U.S. population when preparing their risk assessments used to set National Ambient Air Quality Standards (NAAQs). Whether monotonic relationships exist below the current 1-h standard or whether there exists a threshold concentration has enormous policy implications in setting NAAQS. The recent decision by the EPA Administrator to create a more stringent O3 standard is predicated upon the existence of such a monotonic relationship. Although the authors' conclusions are consistent with the Administrator's action, these data do not support it.

George T. Wolff

General Motors Public Policy Center
Detroit, Michigan


6. Thurston, G. D., M. Lippman, M. B. Scott, and J. M. Fine. 1997. Summertime haze air pollution and children with asthma. Am. J. Respir. Crit. Care Med. 155: 654-660 [Abstract].




    From the Author :

In our children's asthma camp study, we found significant associations between increased daily maximum ozone concentrations in ambient air in rural Connecticut and (1) increased numbers of asthma attacks (as indicated in this study by increased doctor-diagnosed beta-agonist medication use; (2) decreased lung function; and (3) increased respiratory symptoms. The fact that Dr. Wolff is able to drive these associations to statistical nonsignificance by removing up to 4 of the 15 study days is not surprising to those who have studied statistics. Reducing the number of observations in a data set increases the standard error of the estimate (in this case, of the slope), which in turn reduces the statistical significance of the relationship. Thus, Dr. Wolff's reanalysis "results" are more likely due to a lack of power in the reduced data set analysis to detect an effect, rather than to any purported lack of an effect by ozone at levels below a 120 ppb 1-h maximum.

As Dr. Wolff is so interested in this question, I have taken the summary data from this study (i.e., as daily averages of over 50 children on each study day) and applied a more robust data smoothing approach to search for any indication of a threshold of effects (using the statistical package S-Plus [Seattle, WA]). I show the result of this effort for the case of the mean number of beta-agonist medications, as prescribed for the children each day by our on-site physicians, plotted versus the daily ozone concentration (Figure 1). This plot suggests a threshold at approximately 80 ppb daily 1-h maximum, which would convert to a much lower 8-h average threshold value (at roughly 60-70 ppb). Thus, if there is a threshold in these data, it would appear from this smoothed plot to be well below the old 120 ppb 1-h ozone standard. The smoothed plots of lung function change and chest symptoms (not presented here) similarly suggest thresholds, if any, occurring below a 120 ppb 1-h maximum value. Therefore, a more suitable examination for thresholds in these data suggests that the U.S. EPA indeed acted appropriately in tightening the ozone standard in 1997.


View larger version (21K):
[in this window]
[in a new window]
 
Figure 1.   A smoothed plot of physician-prescribed daily beta- agonist medications required by children at a summer "Asthma Camp."

An analysis of a much larger data set, having a greater statistical power, is really needed to more definitively answer Dr. Wolff's threshold question, especially if his approach of selective data deletion is to be employed.

George D. Thurston

NYU School of Medicine
Nelson Institute of Environmental MedicineTuxedo, New York






This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolff, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolff, G. T.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society